Investing.com - Biocept (NASDAQ:BIOC) reported on Friday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Biocept announced earnings per share of $-0.310 on revenue of $10.61M. Analysts polled by Investing.com anticipated EPS of $-0.230 on revenue of $8.95M.
Biocept shares are down 53.92% from the beginning of the year, still down 81.80% from its 52 week high of $4.40 set on December 1, 2021.
Biocept follows other major Healthcare sector earnings this month
Biocept's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar